Ieq Capital LLC Has $3.75 Million Stock Holdings in Colgate-Palmolive (NYSE:CL)

Ieq Capital LLC increased its holdings in Colgate-Palmolive (NYSE:CL) by 22.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,617 shares of the company’s stock after acquiring an additional 7,130 shares during the period. Ieq Capital LLC’s holdings in Colgate-Palmolive were worth $3,747,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Main Street Research LLC boosted its holdings in Colgate-Palmolive by 1.5% during the second quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock worth $673,000 after purchasing an additional 100 shares during the last quarter. Advisor OS LLC boosted its stake in shares of Colgate-Palmolive by 4.5% in the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock worth $228,000 after buying an additional 101 shares during the last quarter. BLB&B Advisors LLC grew its holdings in shares of Colgate-Palmolive by 2.5% in the second quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock valued at $421,000 after acquiring an additional 104 shares in the last quarter. ZWJ Investment Counsel Inc. increased its position in shares of Colgate-Palmolive by 3.1% during the second quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock valued at $349,000 after acquiring an additional 109 shares during the last quarter. Finally, Hexagon Capital Partners LLC lifted its holdings in Colgate-Palmolive by 9.5% during the second quarter. Hexagon Capital Partners LLC now owns 1,274 shares of the company’s stock worth $124,000 after acquiring an additional 110 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE:CL opened at $103.06 on Friday. The company has a 50 day moving average of $102.71 and a 200 day moving average of $95.83. The company has a current ratio of 1.06, a quick ratio of 0.70 and a debt-to-equity ratio of 16.90. The stock has a market cap of $84.55 billion, a P/E ratio of 32.61, a P/E/G ratio of 3.72 and a beta of 0.40. Colgate-Palmolive has a 12 month low of $67.62 and a 12 month high of $109.30.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating analysts’ consensus estimates of $0.87 by $0.04. The firm had revenue of $5.06 billion during the quarter, compared to analyst estimates of $5 billion. Colgate-Palmolive had a net margin of 14.21% and a return on equity of 470.19%. The business’s revenue for the quarter was up 4.9% on a year-over-year basis. During the same period in the previous year, the business earned $0.77 EPS. As a group, sell-side analysts forecast that Colgate-Palmolive will post 3.57 EPS for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.94%. The ex-dividend date is Friday, October 18th. Colgate-Palmolive’s payout ratio is 63.29%.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on the company. HSBC reaffirmed a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Hsbc Global Res lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. Deutsche Bank Aktiengesellschaft cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and boosted their target price for the company from $107.00 to $109.00 in a research note on Monday, September 9th. Stifel Nicolaus raised their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, July 22nd. Finally, BNP Paribas initiated coverage on Colgate-Palmolive in a research note on Monday, June 24th. They issued an “outperform” rating and a $109.00 price objective on the stock. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $102.79.

Insider Buying and Selling

In other news, insider Sally Massey sold 15,850 shares of the stock in a transaction on Tuesday, August 6th. The shares were sold at an average price of $103.28, for a total value of $1,636,988.00. Following the transaction, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Colgate-Palmolive news, insider Sally Massey sold 15,850 shares of Colgate-Palmolive stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares of the company’s stock, valued at $1,439,929.76. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction dated Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The disclosure for this sale can be found here. Over the last three months, insiders have sold 43,490 shares of company stock worth $4,486,063. Insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.